Gastroesophageal | sciencenewsnet.in

Breaking News

How one UIC student is proposing to advance science of superconductivity

Ensuring a bright future for diamond electronics and sensors

New Jersey Voters Rank Economy as No. 1 Issue, Followed by Immigration, Character and Reproductive Rights

Scientists’ ‘next-generation’ space materials blast off for tests on ISS

Explaining Science Through Dance

Selenium raised pharmaceutical value of garden sage

“The Southern Advanced Photon Source (SAPS)” by Prof. Hesheng Chen

Structural Safety Monitoring of Buildings with Color Variations

Meal timing may be crucial for night shift workers’ health

Out of Africa: UT Southwestern cardiologist gets to the heart of Zambia’s No. 1 health threat

05 Nov, 2024

Clinical Trial Results Published in Nature Medicine Show Immunotherapy’s Potential in Resectable Esophageal and Gastroesophageal Junction Cancers and the Benefits of Monitoring Circulating Tumor DNA (ctDNA) to Measure Disease Response

March 20, 2024 sarah JonasResearch Results

The results of a study published today in Nature Medicine show exciting immune responses in patients with operable esophageal or gastroesophageal cancers given neoadjuvant immunotherapy. The study results also show the potential for monitoring circulating tumor DNA as a predictor for future intervention.